Suspected Malignant Hyperthermia in a Brain-Dead Donor During Anesthesia for Organ Procurement Surgery: A Case Report

Transplant Proc. 2023 Oct;55(8):1893-1895. doi: 10.1016/j.transproceed.2023.08.002. Epub 2023 Aug 30.

Abstract

We report an unusual case of highly suspected malignant hyperthermia after inducing anesthesia in a brain-dead 18-year-old male patient undergoing organ procurement surgery. The patient was administered desflurane (3 vol%) and rocuronium bromide (50 mg) to induce and maintain general anesthesia. He experienced hypercapnia and tachycardia within 5 minutes of anesthesia induction; however, his body temperature rapidly rose only after 15 minutes. The volatile anesthetic was discontinued, and dantrolene was administered at a low dose (1 mg/kg) to avert possible hepatotoxic effects on the donor liver. Fortunately, the clinical course of the brain-dead donor until the organs were harvested and the liver transplantation outcome of the recipient was favorable. A comprehensive understanding of the pathophysiology of brain death, organ transplantation, and malignant hyperthermia is essential to respond promptly and appropriately. Based on our experience, low-dose dantrolene may be clinically used in brain-dead donors while accounting for its potential hepatotoxic effects.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anesthesia, General / adverse effects
  • Brain
  • Brain Death
  • Dantrolene / therapeutic use
  • Humans
  • Liver Transplantation* / adverse effects
  • Living Donors
  • Male
  • Malignant Hyperthermia* / diagnosis
  • Malignant Hyperthermia* / etiology
  • Tissue and Organ Procurement*

Substances

  • Dantrolene